Dr. Daniel Rifkin, MD, MPH

Dr. Daniel Rifkin, MD, MPH is a prominent figure in the field of sleep medicine and healthcare innovation. He is the founder and Chief Executive Officer of Ognomy, a groundbreaking healthcare service that has revolutionized the diagnosis and treatment of sleep apnea.13

Professional Background

Dr. Rifkin is a board-certified neurologist with over two decades of experience in sleep medicine.1 His career highlights include:

• Founder and CEO of Ognomy: Launched in February 2021, Ognomy is the first healthcare service to fully transition sleep apnea diagnosis and care from clinical settings to patients' homes.12

• Founder and Medical Director: Established the Sleep Medicine Centers of Western New York in 2002, providing care for various sleep disorders.1

• Academic Role: Serves as a clinical assistant professor of neurology at the University at Buffalo, where he teaches and conducts clinical research.1

Education

Dr. Rifkin's educational background is comprehensive:

• Doctor of Medicine (M.D.) from the Geisel School of Medicine at Dartmouth2
• Master of Public Health (MPH) in Global Health from The George Washington University2
• Bachelor's Degree from Hamilton College2

Innovation in Sleep Medicine

Under Dr. Rifkin's leadership, Ognomy has transformed sleep apnea care:

1. Home-based Diagnosis: Utilizes FDA-approved home sleep tests instead of relying solely on in-laboratory testing.3

2. Data-driven Improvements: Implements an analytics layer to enhance patient experience and make UX improvements.3

3. Expanded Platform: Developed Ognomy into an end-to-end platform, enabling home health companies to offer virtual care and serving as a SaaS product for physicians nationwide.3

Dr. Rifkin's innovative approach has positioned Ognomy at the forefront of sleep medicine technology, continuously exploring new ways to improve patient care and treatment accessibility.3